Latent Tuberculosis clinical trials

Explore recruiting latent tuberculosis clinical trials.

Recruiting latent tuberculosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Latent Tuberculosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Comparison of treatment completion rates with three short-course rifamycin-based regimens (three months of daily isoniazid plus rifampicin [3HR], three months of once-weekly isoniazid plus rifapentine [3HP], and four months of daily rifampicin [4R]) for treatment of latent tuberculosis infection in patients with end-stage kidney disease: A randomised controlled clinical trial (RIFAKiD-TB Trial)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Latent Tuberculosis trials by city

Latent Tuberculosis in Toronto Latent Tuberculosis in Vancouver Latent Tuberculosis in Montreal Latent Tuberculosis in Calgary Latent Tuberculosis in Edmonton Latent Tuberculosis in Ottawa Latent Tuberculosis in Winnipeg Latent Tuberculosis in Quebec City Latent Tuberculosis in Hamilton Latent Tuberculosis in Kitchener Latent Tuberculosis in London Latent Tuberculosis in Halifax Latent Tuberculosis in New York Latent Tuberculosis in Los Angeles Latent Tuberculosis in Chicago Latent Tuberculosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease